Oxford Biomedica signs new deal to make AstraZeneca COVID shot

Oxford Biomedica signs new deal to make AstraZeneca COVID shot

By, Admin 4 July 2022

Under the expanded deal, AstraZeneca's will have access to Oxford Biomedica's Oxbox manufacturing facility to produce its shot on an as-needed basis beyond 2022. Britains Oxford Biomedica said on Friday it had signed a new three-year agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022, but no volumes were defined in an indication of waning demand for the shot. Cell and gene therapy firm Oxford Biomedica said in April that it had manufactured more than 100 million doses of AstraZeneca's vaccine since their partnership began in September 2020. Commitments under the deal are scheduled to end this year. Under the expanded deal, AstraZeneca's will have access to Oxford Biomedica's Oxbox While it is positive that AZ wanted a longer-term relationship with OXB, and that uncertainty is now diminished, we had expected a bigger deal," RBC analysts said in a note. Oxford Biomedica expects to record about 30 million pounds ($36.4 million) in revenue from the original contract in the current year. ($1 = 0.8241 pounds)

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!